The expansion will add 10 KL of SPPS reactor capacity and establish six parallel cGMP manufacturing lines to support peptide ...
The sectors recorded 19 funding rounds during the month, with funding rising 6.91 per cent year on year and falling 7.35 per ...
Lupin has announced the launch of Raltegravir Tablets USP, 600 mg in the United States, following approval from the US Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA ...
The appointment brings over four decades of experience in business development, corporate strategy, finance, governance and mergers and acquisitions to the Board ...
Under the existing agreement, injectable lenacapavir will be available at US$40 per person per year across 120 countries covered by Gilead’s voluntary licence.
Contract follows successful Process Development and scale-up of a new product, marking a key commercial milestone for ...
The agreement with Janssen Sciences Ireland enables commercialisation of the proposed Stelara biosimilar in Australia, Brazil ...
The certification follows inspections by Brazil’s ANVISA and Japan’s PMDA, supporting Hikal’s expansion across regulated ...
AIIA-iCAINE launches an IPR facility, signs two MoUs with the World Ayurveda Foundation and Reliance Retail, and conducts a ...
The partnership covers Europe, the Americas and selected Rest of World markets for the twice-daily extended-release tramadol ...
The projects will focus on investigational therapies for advanced keratopathy and wet age-related macular degeneration, with ...
What gaps in India’s dermatology and skincare market led to the creation of Puresta, and how does the company plan to build a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results